High-resolution HLA-DRB1 and DQB1 genotyping in Japanese patients with testicular germ cell carcinoma

British Journal of Cancer

Volumn 76, Issue 10, 1997, Pages 1348-1352

  Ozdemir E ^a   Kakehi, Y ^a   Mishina, M ^a   Ogawa, O ^a   Okada, Y ^a   Ozdemir D ^a   Yoshida, O ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Allele frequency; MHC class II genotyping; Modified PCR RFLP; Testicular germ cell carcinoma

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; GERM CELL TUMOR; HUMAN; HUMAN CELL; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROTYPING; TESTIS CARCINOMA;

EID: 0030658960     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.559     Document Type: Article

References (28)

1. Aiginger P, Kuzmits R, Kradzig C, Schwarz HP, Zielinski CC, Kühböck J and Mayr WR (1987) HLA antigens and germ cell tumours. Lancet 1: 276-277
2. Akuza T, Imanishi T, Fujiwara K, Tokunaga K, Juji T, Yahiki S and Sonoda S (1994) HLA alleles and haplotype frequencies in Japanese. Transplant Now 7 (suppl.): 87-99
3. Ayala FJ (1995) The myth of Eve: molecular biology and human origins. Science 270: 1930-1936
4. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frödin L, Glattre E, Halverson S, Holm NV, Jakobsen A, Jorgensen HE, Ladefoget J, Lindholm T, Lundgren G and Pukkala E (1995) Cancer risk after renal transplantation in Nordic countries. 1964-1986. Int J Cancer 60: 189-189
5. DeWolf WC, Lange PH, Einarson ME and Yunis EJ (1979) HLA and testicular cancer. Nature 277: 216-217
6. Futami S, Aoyama N, Honsako Y, Tamura T, Morimoto S, Nakashima T, Ohmoto A, Okano H, Miyamoto M, Inaba H, Naruse T, Nose Y and Kasuga M (1995) HLA-DRBI*1502 allele. subtype of DR15. is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci 40: 814-818
7. Glew SS, Stern PS, Davidson JA and Dyer PA (1992) HLA antigens and cervical carcinoma. Nature 356: 22
8. Green A (1982) The epidemiologic approach to studies of association between HLA and disease. Tissue Antigens 19: 245-268
9. Ichikawa Y, Hashimoto M, Nojima M, Sata M, Fujimoto N, Kyo M, Ishibashi M, Ohshima S, Amemiya H, Fukunishi T, Nagano S and Sonoda T (1993) The significant effect of HLA-DRBI matching on long-term kidney graft outcome Transplantation 56: 1368-1371
10. Kradzig C, Aiginger P, Kuzmits R, Spona J, Kirnbauer M, Seiser A and Mayr WR (1984) HLA-antigen distribution in seminoma, HCG-positivc seminoma and non-seminomatous tumours of the testis. Urol Res 17: 377-380
11. Lee JE, Reveille JD, Ross MI and Platsoucas CD (1994) HLA-DQB*0301 association with increased cutaneous melanoma risk. Int J Cancer 59: 510-513
12. Mostofi FK and Sobin LH (1977) Histological typing of testis tumours. In International Histological Classification of tumors, No. 16 World Health Organization: Geneva
13. Nomura N, Ota M, Tsuji K and Inoko H (1991) HLA-DQBI genotyping by a modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 38: 53-59
14. Oliver RTD, Stephenson CA, Parkinson MC, Forman D, Atkinson A, Bodmer J and Bodmer WF (1986) Germ cell tumors of the testicle as a model of MHC influence on human malignancy. Lancet 1: 1506
15. Ota M, Seki T, Fukushima H, Tsuji K and Inoko H (1992) HLA-DRB1 geontyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 39: 187-202
16. Özdemir E, Kakehi Y, Nakamura E, Kinoshita H, Terachi T, Okada Y and Yoshida O (1997) HLA-DRBI*0101 and *0405 as protective alleles in Japanese patients with renal cell carcinoma Cancer Res 57: 742-746
17. Perucho M, Goldfarh M, Shimizu K, Lama C, Fogh J and Wigler M (1981) Human tumor-derived cell lines contain common and different transforming genes. Cell 27: 467-476
18. Pollack MS and Livingstone IQ (1985) HLA and DR antigen frequencies in melanoma patients: possible relation to disease prognosis. Tissue Antigens 26: 262-265
19. Pollack MS, Vugrin D, Hennessy W, Herr HW. Dupont B and Whitmore WF (1982) HLA antigens in patients with germ cell cancers of the testis. Cancer Res 42: 2470-2473
20. Richie JP (1992) Neoplasms of the testis. In Campbell's Urology. Walsh PC, Retik AB, Stamey TA and Vaughan ED (eds). pp. 1222-1255. W.B. Saunders: Philadelphia
21. Rukstalis DB, Bubley GJ, Donahue JP, Richie JP, Seidman JG and De Wolf WC (1989) Regional loss of chromosome 6 in two urological malignancies, Cancer Res 49: 5087-5090
22. Senturia YD (1987) The epidemiology of testicular cancer. Br J Urol 60: 285-291
23. Smeraldi RS, Luzzarin A, Moroni M, Fabio G, Eisera NB and Zanussi C (1986) HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet 2: 1187-1189
24. Thomson G (1981) A review of theoretical aspects of HLA and disease associations. Theor Popul Biol 20: 168-208
25. Tiercy JM, Morel J, Friedel AC, Zwahlen F, Gebuhrer L, Betuel H, Jeannet M and Mach B (1991) Selection of unrelated donors for hone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization. Proc Natl Acad Sci USA 88: 7121 -7125
26. Tolerud D, Blattner WA, Fraser MC, Brown LM, Pottern L, Shapiro E, Kirkemo A, Shawker TH, Jevadpour N, O'Connell K, Stutzman RE and Fraumeni JF (1985) Familial testicular cancer and urogenital developmental anomalies. Cancer 55: 1849-1854
27. Union Internationale Contre Le Cancer (1989) The TNM Classification of Malignant Tumours. 3rd edn. Springer: Berlin
28. Yoshimura K, Nishimura K, Miyoshi S, Mizutani S, Mise T and Iwasa K (1993) Father-son testicular cancer. Urol Int 50: 108-110